Titre:
  • Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
Auteur:Fizazi, Karim; Lipton, Allan; Mariette, Xavier; Body, Jean-Jacques; Rahim, Yasmin; Gralow, Julie R; Gao, Guozhi M.; Wu, Ling; Sohn, Winnie; Jun, Susie
Informations sur la publication:Journal of clinical oncology, 27, 10, page (1564-1571)
Statut de publication:Publié, 2009-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Aged
Antibodies, Monoclonal -- pharmacokinetics -- therapeutic use
Antibodies, Monoclonal, Humanized
Bone Density Conservation Agents -- therapeutic use
Bone Neoplasms -- complications -- secondary
Bone Resorption -- chemically induced -- prevention & control
Breast Neoplasms -- pathology
Collagen Type I -- urine
Diphosphonates -- administration & dosage
Female
Humans
Male
Middle Aged
Multiple Myeloma -- pathology
Peptides -- urine
Prostatic Neoplasms -- pathology
RANK Ligand -- antagonists & inhibitors -- pharmacokinetics -- therapeutic use
Note générale:Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2008.19.2146
info:pii/JCO.2008.19.2146
info:scp/63749094012
info:pmid/19237632